AEON Biopharma, Inc. Earnings Per Share (Basic)
AEON Biopharma, Inc. (AEON) reported Earnings Per Share (Basic) of -$0.02 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-12
- AEON Biopharma, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.02.
- AEON Biopharma, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.29, a 112.72% decline year-over-year.
- AEON Biopharma, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.39.
- AEON Biopharma, Inc. earnings per share, basic for the quarter ending 2025-06-30 was -$0.60, a 100.20% decline year-over-year.
- AEON Biopharma, Inc. earnings per share, basic for fiscal 2025 was -$3.95, a 105.08% decline from fiscal 2024.
- AEON Biopharma, Inc. earnings per share, basic for fiscal 2024 was $77.74.
- AEON Biopharma, Inc. earnings per share, basic for fiscal 2022 was -$0.38.
| Period end | Earnings Per Share, Basic 1 month | Earnings Per Share, Basic 1 month as first filed | Earnings Per Share, Basic 2 month | Earnings Per Share, Basic 2 month as first filed | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 5 month | Earnings Per Share, Basic 5 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 7 month | Earnings Per Share, Basic 7 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.02 10-Q · filed 2026-08-12 | -$0.28 10-Q · filed 2026-08-12 | |||||||||||||
| 2026-03-31 | -$0.29 10-Q · filed 2026-05-14 | ||||||||||||||
| 2025-12-31 | -$3.95 10-K · filed 2026-03-30 | ||||||||||||||
| 2025-09-30 | -$0.39 10-Q · filed 2025-11-14 | -$0.23 10-Q · filed 2025-11-14 | |||||||||||||
| 2025-06-30 | -$0.60 10-Q · filed 2026-08-12 | $0.32 10-Q · filed 2026-08-12 | |||||||||||||
| 2025-03-31 | $2.28 10-Q · filed 2026-05-14 | ||||||||||||||
| 2024-12-31 | $77.74 10-K · filed 2026-03-30 | ||||||||||||||
| 2024-09-30 | -$11.24 10-Q · filed 2025-11-14 | -$0.16 10-Q · filed 2024-11-13 | $74.53 10-Q · filed 2025-11-14 | $1.04 10-Q · filed 2024-11-13 | |||||||||||
| 2024-06-30 | $304.00 10-Q · filed 2025-08-12 | $4.22 10-Q · filed 2024-08-12 | $87.15 10-Q · filed 2025-08-12 | $1.21 10-Q · filed 2024-08-12 | |||||||||||
| 2024-03-31 | -$227.87 10-Q · filed 2025-05-14 | -$3.17 10-Q · filed 2024-05-14 | |||||||||||||
| 2023-12-31 | -$627.33 10-K · filed 2025-03-24 | $0.65 10-K · filed 2024-03-29 | |||||||||||||
| 2023-09-30 | $1.35 10-Q/A · filed 2024-03-29 | ||||||||||||||
| 2023-07-21 | -$0.20 10-Q · filed 2024-11-13 | -$0.04 10-Q · filed 2023-11-13 | -$0.44 10-K · filed 2025-03-24 | -$0.28 10-Q · filed 2023-11-13 | |||||||||||
| 2023-06-30 | -$0.11 10-Q · filed 2024-08-12 | -$0.24 10-Q · filed 2024-08-12 | |||||||||||||
| 2023-03-31 | -$0.13 10-Q · filed 2024-05-14 | -$0.38 derived: net income ÷ weighted average shares · filed 2024-05-14 | -$0.45 derived: net income ÷ weighted average shares · filed 2024-05-14 | ||||||||||||
| 2022-12-31 | -$0.25 derived: net income ÷ weighted average shares · filed 2024-05-14 | -$0.32 derived: net income ÷ weighted average shares · filed 2024-05-14 | -$0.38 10-K/A · filed 2024-05-14 | ||||||||||||
| 2022-09-30 | -$0.08 10-Q/A · filed 2024-03-29 | -$0.13 10-Q/A · filed 2024-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |